You searched for - Page 65 of 145 - KFF Health News

Under Trump, Hospitals Face Same Penalties Embraced By Obama

By Jordan Rau August 3, 2017 KFF Health News Original

Federal records show that 2,573 hospitals around the country will have their Medicare payments reduced because they have too many patients readmitted.

Trump’s Order Advances GOP Go-To Ideas To Broaden Insurance Choices, Curb Costs

By Julie Appleby October 12, 2017 KFF Health News Original

But the approaches are not new and critics worry that these changes will leave some consumers with skimpier plans that expose them to high medical bills.

Right After Trump Blamed High Drug Prices On Campaign Cash, Drugmakers Gave More

By Sydney Lupkin and Elizabeth Lucas September 27, 2017 KFF Health News Original

At a political rally in March, President Donald Trump said drug prices are “outrageous” and blamed campaign contributions. Drugmakers funneled nearly $280,000 to Congress the very next day.

California Scrambles To Contain ‘Unprecedented’ Hepatitis A Outbreaks

By Stephanie O'Neill September 26, 2017 KFF Health News Original

Hundreds of people, most of them homeless, have been infected. In San Diego County, where 17 people have died, critics fault authorities for being slow to act.

Senate Bipartisan Bill To Curb Opioid Crisis Includes 3-Day Prescription Limit, $1B In Additional Funding

February 28, 2018 Morning Briefing

Lawmakers are aggressively ramping up their efforts to fight the nation’s drug epidemic. In addition to the new measure, chairs of the two primary health committees in Congress pledged to push more legislation within the next months.

Moms Of Children With Rare Genetic Illness Push For Wider Newborn Screening

By Anna Gorman October 5, 2017 KFF Health News Original

California is one of only a handful of states nationwide that screens babies for the gene mutation that causes a rare brain disease — a test that dramatically increases a sick child’s chances of survival.

Hospitals Find Asthma Hot Spots More Profitable To Neglect Than Fix

By Jay Hancock and Rachel Bluth and Daniel Trielli December 6, 2017 KFF Health News Original

Months of reporting and rich hospital data portray life in the worst asthma hot spot in one of the worst asthma cities: Baltimore. The medical system knows how to help. But there’s no money in it.

Half The Time, Nursing Homes Scrutinized On Safety By Medicare Are Still Treacherous

By Jordan Rau July 6, 2017 KFF Health News Original

Of the 528 nursing homes that graduated from special focus status before 2014 and are still operating, more than half — 52 percent — have harmed patients or operated in a way that put patients in serious jeopardy within the past three years, a KHN analysis finds.

Federal Money For State-Level Zika Tracking, Prevention May End This Summer

By Ana B. Ibarra May 2, 2017 KFF Health News Original

California has reported more than 500 travel-related Zika infections, and five babies have been born in the state with birth defects related to the mosquito-borne disease.

Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don’t We?

By Jay Hancock September 25, 2017 KFF Health News Original

Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.

Tension Heats Up On Capitol Hill Over Drug Discount Program As Cuts Go Into Effect

January 3, 2018 Morning Briefing

Hospitals and big pharma are waging a war over the 340B program, which requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients.

CVS To Use $1.5B Windfall From GOP Tax Plan To Raise Hourly Wages For Workers

February 9, 2018 Morning Briefing

The company also said it will invest in technology that can help it track prescription drug use or monitor data like blood tests to determine if a patient’s health or a condition grows worse.

Senate Democrats Push For Additional $25B In Opioid Funding In Federal Budget

January 10, 2018 Morning Briefing

“Make no mistake: This is a national public health emergency, and we still don’t see a robust federal response. The current federal budget negotiations give us an opportunity to right this wrong,” said Sen. Jeanne Shaheen (D-N.H.), who is working with Sen. Maggie Hassan (D-N.H.) to get more money. In related news, journalist Sam Quinones testified as a rare single witness during a Senate hearing on the drug epidemic. And opioids emerge as a campaign issue in the primary election battle of onetime drug czar nominee Rep. Tom Marino (R-Pa.)

To Grow Market Share, A Drugmaker Pitches Its Product To Judges

By Jake Harper, Side Effects Public Media August 4, 2017 KFF Health News Original

Some drug courts offer participants a full range of evidence-based treatment, including medication-assisted treatment. Others don’t allow addiction medications at all. And some permit just one: Vivitrol.

As California Weighs Soda Warning Labels, Tax In Berkeley Shown To Dilute Sales

By Ana B. Ibarra April 19, 2017 KFF Health News Original

Sales of sugary drinks dropped in the city by nearly 10 percent a year after tax took effect in 2015, while bottled water sales rose, researchers report.

Federal Judge Clears Way For Sharp Cuts To Medicare’s 340B Program

January 2, 2018 Morning Briefing

Hospitals had sought to block $1.6 billion in Trump administration cuts to the program, which lets some hospitals buy drugs at discounted prices.

Move To End DACA Leaves Some Young Immigrants Fearing For Their Health

By Barbara Feder Ostrov and Anna Gorman September 6, 2017 KFF Health News Original

The Deferred Action for Childhood Arrivals program made it possible for young adults who came into the country illegally as children to get jobs with insurance and, in some states including California, Medicaid. Now that coverage is in peril.

Pfizer Announces Plans To Invest $5B In U.S. Manufacturing Citing Positive Tax Law Revisions

January 31, 2018 Morning Briefing

The pharmaceutical giant said it will also hand out one-time bonuses this quarter to non-executive employees.

Without Price Breaks, Rural Hospitals Struggle To Stock Costly, Lifesaving Drugs

By Sarah Jane Tribble September 18, 2017 KFF Health News Original

A federal drug program blocks rural hospitals from getting discounts on rare-disease drugs, forcing staff to cut back on supplies of lifesaving medicines.

Follow The Money: Drugmakers Deploy Political Cash As Prices And Anger Mount

By Jay Hancock and Elizabeth Lucas and Sydney Lupkin July 24, 2017 KFF Health News Original

Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.

Filter Results

More From KFF Health News